Kymera Therapeutics (KYMR) EV to FCF (2020 - 2021)
Kymera Therapeutics' (KYMR) EV to FCF was 34.30 for Q2 2021, up 69.0% from the prior quarter.
Analysis
Kymera Therapeutics (KYMR) EV to FCF (2020 - 2021) Analysis & Trends
Over the twelve months ended Jun 30, 2021, Kymera Therapeutics' EV to FCF came in at 17.07; for FY2020, it was 9.86.
- Per Business Quant data, the three quarters before Q2 2021 came in at 20.29 (Q1 2021), 9.86 (Q4 2020) and 4.18 (Q3 2020).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Kymera Therapeutics | 9.25 Bn | 6.56 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2021 | 34.30 |
| Mar 31, 2021 | 20.29 |
| Dec 31, 2020 | 9.86 |
| Sep 30, 2020 | 4.18 |
API Access
Kymera Therapeutics EV to FCF API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=KYMR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-fcf", "ticker": "KYMR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=KYMR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();